Stavudine (2′,3′-didehydro-2′,3′-dideoxythymidine, d4T, brand name Zerit) is an antiretroviral medication used to prevent and treat HIV/AIDS It is of the nucleoside analog reverse-transcriptase inhibitor (NRTI) class.
Adverse events
The main severe adverse effect is peripheral neuropathy, which can be corrected by reducing dosage. Stavudine has been shown in laboratory test to be genotoxic, but with clinical doses its carcinogenic effects are non-existent. It is also one of the most likely antiviral drugs to cause lipodystrophy, and for this reason it is no longer considered an appropriate treatment for most patients in developed countries [sic].
On Feb, 18, 2016: 8,527 people reported to have side effects when taking Zerit. Among them, 25 people (0.29%) have Hallucination.
Time on Zerit when people have Hallucination :
|
< 1 month |
1 - 6 months |
6 - 12 months |
1 - 2 years |
2 - 5 years |
5 - 10 years |
10+ years |
Hallucination |
0.00% |
0.00% |
0.00% |
100.00% |
0.00% |
0.00% |
0.00% |
Gender of people who have Hallucination when taking Zerit :
|
Female |
Male |
Hallucination |
52.00% |
48.00% |
Age of people who have Hallucination when taking Zerit :
|
0-1 |
2-9 |
10-19 |
20-29 |
30-39 |
40-49 |
50-59 |
60+ |
Hallucination |
0.00% |
0.00% |
9.09% |
4.55% |
27.27% |
45.45% |
9.09% |
4.55% |
On Feb, 18, 2016: 8,527 people reported to have side effects when taking Zerit. Among them, 98 people (1.15%) have Death.
Time on Zerit when people have Death :
|
< 1 month |
1 - 6 months |
6 - 12 months |
1 - 2 years |
2 - 5 years |
5 - 10 years |
10+ years |
Death |
4.44% |
11.11% |
13.33% |
13.33% |
35.56% |
20.00% |
2.22% |
Gender of people who have Death when taking Zerit :
|
Female |
Male |
Death |
35.64% |
64.36% |
Age of people who have Death when taking Zerit :
|
0-1 |
2-9 |
10-19 |
20-29 |
30-39 |
40-49 |
50-59 |
60+ |
Death |
0.00% |
2.27% |
2.27% |
7.95% |
22.73% |
48.86% |
6.82% |
9.09% |
Top conditions involved for these people :
- Hiv infection (41 people, 41.84%)
- Hiv test positive (4 people, 4.08%)
- Acquired immunodeficiency syndrome (4 people, 4.08%)